Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


SIEBERT JOHN M Create: Alert

All | News | Filings
Date FiledTypeDescription
02/27/2023 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns: Granted 6,293 options to buy @ $38.6, valued at $242.9k
Granted 3,886 restricted stock units @ $0
02/24/2023 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns: Granted 3,882 shares @ $0
Disposed/sold 3,882 restricted stock units @ $0
02/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.
Txns: Granted 4,222 shares @ $0
Disposed/sold 4,222 restricted stock units @ $0
08/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2019 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
03/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2018 4 SIEBERT JOHN M (Interim Principal Exec Ofcr) has filed a Form 4 on ARADIGM CORP
Txns: Granted 276,000 options to buy @ $1.31, valued at $361.6k
02/27/2018 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Granted 8,613 options to buy @ $39.4, valued at $339.4k
06/15/2017 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Granted 6,036 options to buy @ $38.6, valued at $233k
06/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/27/2017 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
06/13/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2016 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Granted 15,000 options to buy @ $12.98, valued at $194.7k
11/16/2015 4 SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns: Granted 19,940 options to buy @ $6.5, valued at $129.6k
03/05/2015 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Granted 20,000 options to buy @ $9.13, valued at $182.6k
01/13/2015 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Exercised 2,188 options to buy @ $4.24, valued at $9.3k
04/22/2014 4 SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns: Granted 225,000 options to buy @ $0.22, valued at $49.5k
01/23/2014 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
Txns: Exercised 2,187 options to buy @ $4.24, valued at $9.3k
Granted 7,457 options to buy @ $9.24, valued at $68.9k
06/24/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/25/2013 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
12/17/2012 4 SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC
06/01/2012 4 SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns: Granted 100,000 shares @ $0
Granted 140,000 options to buy @ $0.15, valued at $21k
04/30/2012 3 SIEBERT JOHN M (Director) has filed a Form 3 on SUPERNUS PHARMACEUTICALS INC
05/31/2011 4 SIEBERT JOHN M (Director) has filed a Form 4 on ARADIGM CORP
Txns: Granted 78,947 shares @ $0
Granted 100,000 options to buy @ $0.19, valued at $19k
05/18/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
06/05/2009 4/A Form 4/A -- Statement of changes in beneficial ownership of securities [amend]
05/19/2009 4 Form 4 -- Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy